The ARDVAARC study: real-world outcomes and the utility of bleeding risk scores in patients who require anticoagulation following percutaneous coronary intervention (PCI)
Event:
ESC Congress 2018
Topic:
Adjunctive Pharmacotherapy
Session:
Risk scores at coronary revascularisation
